At a glance
- Originator Pharmacia Corporation
- Class Antiasthmatics; Small molecules
- Mechanism of Action Leucocyte elastase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Respiratory tract disorders
Most Recent Events
- 25 Feb 1999 No-Development-Reported for Respiratory tract disorders in European Union (Unknown route)
- 20 Sep 1996 Preclinical development for Respiratory tract disorders in European Union (Unknown route)